The economic valuation of the inhalation lab equipment sector has grown steadily alongside the global pharmaceutical market. As the "patent cliff" forces companies to innovate, there is a renewed focus on respiratory medicine, which has historically been underserved compared to oncology or cardiology. This has led to a surge in the procurement of high-end inhalation towers and automated lung...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt